Breast and prostate cancer patients differ significantly in their serum Thymidine kinase 1 (TK1) specific activities compared with those hematological malignancies and blood donors: implications of…

Overview of attention for article published in BMC Cancer, February 2015

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (82nd percentile)
High Attention Score compared to outputs of the same age and source (92nd percentile)

Mentioned by

patent: 2 patents

wikipedia: 3 Wikipedia pages

Citations

dimensions_citation: 36 Dimensions

Readers on

mendeley: 36 Mendeley

Summary Patents Wikipedia Dimensions citations

So far, Altmetric has seen 2 patents that reference this research output.

PREDICTING PATIENT SURVIVAL

Application EP-4097479-A4

European Patent Office

SUPERACTIVE MUTANT THYMIDINE KINASE FOR USE IN CANCER THERAPY

Application WO-2019020702-A1

World Intellectual Property Organisation (WIPO)

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.